Galileo Life Sciences (MDRM) Inactive 10-Q2015 Q2 Quarterly report

Filed: 22 Feb 16, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: accredited, ActiVein, Additionally, aforementioned, alleging, alternate, amended, amending, appointed, arbitration, assembly, attract, avoid, Baseer, bear, blood, bring, calendar, call, capable, carrier, claim, comply, concerted, construction, cooperation, counsel, Court, crated, currency, Declan, delay, depreciation, detail, director, discretion, dollar, eighty, employment, enforce, entitled, equipment, escrow, essential, exempt, expediting, explained, extent, external, failed, fairly, February, Floroff, forthcoming, freely, French, Friedman, full, galileo, Gilbert, hundred, imposed, index, inflation, investor, IP, IV, Jeffrey, Kenneth, Khan, land, lease, legend, lender, lieu, manner, matter, method, Mike, mitigate, monetary, mutual, needle, newly, noncompliance, notice, October, opportunity, ownership, panel, performed, personal, pick, Pinckard, placement, platform, prevailing, promulgated, prospective, ratified, recognition, reliance, remaining, renegotiated, renewal, rent, resignation, resigned, resolution, restricted, restrictive, returned, reverse, Safer, Section, serve, Sharpe, small, solar, sought, statutesz, subscription, Superior, temporal, Toronto, translated, translation, turned, unacceptable, undergoing, unique, unsuccessful, vacate, valuable, Vice, view, vote, voting, word

Removed: audit, classification, consisted, corporation, encompassed, estimate, existence, forward, implemented, knowledge, likelihood, located, MDRFM, pending, position, Province, realization, realizing, record, rely, split, threatened

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

MDRM similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Galileo Life Sciences, Inc. (formerly Modern Mobility Aids, Inc), (the "Registrant") on Form 10-Q for the quarterly period ended December 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Preston Shea, President, Acting Chief Financial Officer, Treasurer, Secretary, (Acting Principal Financial Officer and Acting Principal Accounting Officer) of the Registrant, certify, in accordance with 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1)

The Report, to which this certification is attached as Exhibit 32, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant

Dated: February 22, 2016

	By:	/s/ Preston J. Shea
		Preston J. Shea
		President, Chief Financial Officer and Chief Accounting Officer